NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Acclinate

Acclinate

Private
Birmingham, AlabamaHealthcare & Life Scienceshttps://www.acclinate.com/

Last Round

Series A

May 7, 2024

Est. Valuation

$20M

Total Funding Raised

$10.92M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Acclinate is a digital health company that provides a platform leveraging machine learning and predictive analytics to enhance representation and diversity in genomic research and clinical trials by automating participant identification, education, engagement, and retention.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

clinical trial diversitypatient recruitmentDEI in clinical trialshealth equitypredictive enrollment intelligenceparticipation probability indexPPIclinical trial engagementcommunity outreachclinical trial diversity techdiverse patient recruitmenthealth techclinical research diversitytrial diversity softwareclinical trial recruitment platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acclinate Comparables

Compare Acclinate with similar companies based on industry and business-model similarity.

Acclinate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
COUCH Health
72%
Syneos Health
71%
AutoCruitment
71%

Acclinate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 7, 2024
SeedNov 1, 2022
GrantOct 14, 2022
GrantOct 1, 2021
AcceleratorFeb 5, 2021
Pre Seed
Sep 15, 2020

Key People

Founding team and executive leadership

Tiffany Whitlow

Co- Founder Chief Development Officer

Founding Team

Del Smith

CEO Cofounder

Founding Team

Acclinate Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2026

    Co-Founder Tiffany Whitlow named to Inc.'s 2026 Female Founders 500 list.

  • Mar 16, 2026

    NOWINCLUDED Unfiltered podcast aims to expand community footprint.

Acclinate Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acclinate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acclinate's valuation, stock price, and market status.

Firmographic Details

HeadquartersBirmingham, Alabama
Employee Range54
Year Founded2020
Last FundingMay 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.